JOURNAL OF THORACIC ONCOLOGY Journal

publication venue for

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2). 16:327-333. 2021
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC. 14:1794-1806. 2019
Survival with Parenchymal and Pleural Invasion of Non-Small Cell Lung Cancers Less than 30 mm. 14:890-902. 2019
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. 13:1483-1495. 2018
Disparities in Representation of Older Adults, Women, Racial/Ethnic Minorities in Lung Cancer Clinical Trials: Meta-analysis 2023
Control for stochastic sampling variation and qualitative sequencing error in next generation sequencing analysis of KRAS actionable mutations 2016
DIVERSE EFFECTS OF PAI-1 PROTEINS ON LUNG AND PROSTATE CANCER CELL INVASION 2013
PROTEINASE INHIBITION REGULATES THE ANTI-TUMOR ACTIVITY OF PAI-1 TOWARDS LUNG AND PROSTATE CANCER CELLS 2013
"MECHANISM OF PAI-1 ANTI-PROLIFERATIVE ACTIVITY TOWARDS LUNG AND PROSTATE CANCER CELLS" 2011
"PAI-1 REGULATES PROSTATE CANCER BUT NOT LUNG CANCER CELLS INVASIVENESS" 2011
Mutated PAI-1 inhibits proliferative activity of lung cancer cells 2009

category

ONCOLOGY Category
RESPIRATORY SYSTEM Category

International Standard Serial Number (ISSN)

1556-0864

Electronic International Standard Serial Number (EISSN)

1556-1380

journal abbreviation

J THORAC ONCOL